Which stocks in any sector do Indian mutual fund managers prefer most? — July 2026 data
| # | Stock Name | No. of MFs Holding | Avg Weight (%) | Total MF Value (Cr) |
|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 458 funds | 2.65% | ₹59,704 Cr |
| 2 | Torrent Pharmaceuticals Limited | 326 funds | 2.14% | ₹15,463 Cr |
| 3 | Divi's Laboratories Limited | 319 funds | 2.31% | ₹27,445 Cr |
| 4 | Cipla Limited | 284 funds | 1.85% | ₹23,670 Cr |
| 5 | Dr. Reddy's Laboratories Limited | 244 funds | 1.72% | ₹14,242 Cr |
| 6 | Lupin Limited | 238 funds | 1.67% | ₹16,352 Cr |
| 7 | Mankind Pharma Limited | 211 funds | 1.10% | ₹10,942 Cr |
| 8 | Aurobindo Pharma Limited | 204 funds | 1.56% | ₹9,835 Cr |
| 9 | Glenmark Pharmaceuticals Limited | 200 funds | 1.27% | ₹8,171 Cr |
| 10 | Laurus Labs Limited | 197 funds | 2.72% | ₹8,429 Cr |
| 11 | Ajanta Pharma Limited | 190 funds | 0.98% | ₹7,716 Cr |
| 12 | Biocon Limited | 186 funds | 1.02% | ₹12,785 Cr |
| 13 | Alkem Laboratories Limited | 179 funds | 1.18% | ₹11,503 Cr |
| 14 | Zydus Lifesciences Limited | 162 funds | 1.05% | ₹5,469 Cr |
| 15 | Sai Life Sciences Limited | 161 funds | 1.82% | ₹8,268 Cr |
| 16 | Abbott India Limited | 157 funds | 0.94% | ₹4,355 Cr |
| 17 | Anthem Biosciences Limited | 155 funds | 0.64% | ₹4,531 Cr |
| 18 | IPCA Laboratories Limited | 151 funds | 1.10% | ₹13,975 Cr |
| 19 | Acutaas Chemicals Ltd | 149 funds | 1.90% | ₹3,594 Cr |
| 20 | Gland Pharma Limited | 142 funds | 1.85% | ₹11,073 Cr |
The table above ranks the top 20 stocks in the Pharmaceuticals & Biotechnology sector by the number of Indian mutual fund schemes holding them as of July 2026. When a large number of fund managers independently choose the same stock, it is a powerful signal of institutional conviction — these are the stocks that professional money managers believe in most.
A stock held by 200+ mutual funds means that hundreds of fund managers — each doing their own independent research — have concluded that this stock deserves a place in their portfolio. This collective wisdom is one of the most reliable indicators of a stock's quality within its sector. The average weight shows how much of their portfolio each fund typically allocates to the stock, and the total MF value shows the combined rupee investment across all funds holding it.
All data is sourced from monthly portfolio disclosures that every AMFI-registered mutual fund is required to publish. RightAdvise compiles and analyses this data across 1,100+ active fund schemes to give you a clear, unbiased view of where professional fund managers are investing in the Pharmaceuticals & Biotechnology sector. Click any stock name in the table to see which specific funds hold it and in what proportion.